Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Merck KGaA (OTC: MKGAF).

Full DD Report for MKGAF

You must become a subscriber to view this report.


Recent News from (OTC: MKGAF)

Merck KGaA, Darmstadt, Germany Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Pipeline
DARMSTADT, Germany , May 16, 2018 /PRNewswire/ -- Not intended for UK-based media ASCO Abstract # Avelumab: 9507, 9537, 9090, 9008, 8563, 3057, 4544, e21531, e13603, e18932, e21623, e21620, e21544; tepotinib (c-Met kinase inhibitor): 9082, 9016; M6620 (ATR inhibitor): 2549...
Source: PR Newswire
Date: May, 16 2018 21:13
Merck's (MKGAF) Management on Q1 2018 Results - Earnings Call Transcript
Merck KGaA (MKGAF) Q1 2018 Earnings Conference Call May 15, 2018 8:00 a.m. ET Executives Constantin Fest - IR Marcus Kuhnert - CFO Belen Garijo - CEO, Healthcare Analysts Peter Verdult - Citi Simon Baker - Exane Wimal Kapadia - Bernstein Sachin Jain - Bank of America ...
Source: SeekingAlpha
Date: May, 15 2018 11:40
Merck KGaA to develop abituzumab for CRC with SFJ
Merck KGaA ( OTCPK:MKGAF ) will collaborate with SFJ Pharmaceuticals Group to develop abituzumab, in combination Eli Lilly's ERBITUX (cetuximab) and chemo, for the first-line treatment of metastatic colorectal cancer (CRC). More news on: Merck KGaA, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 02 2018 10:02
Key events next week - healthcare
Noteworthy events for the week of April 22 - 28 for healthcare investors. More news on: Navidea Biopharmaceuticals, Galectin Therapeutics, Inc., Eli Lilly and Company, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: April, 20 2018 07:43
Merck's (MKGAF) CEO Stefan Oschmann on Procter & Gamble To Acquire Consumer Health Business - Call Transcript
Merck KGaA (MKGAF) Procter & Gamble To Acquire Consumer Health Business Conference Call April 19, 2018 6:00 AM ET Executives Constantin Fest – Head of Investor Relations Stefan Oschmann – Chairman and Chief Executive Officer Belén Garijo – Member of ...
Source: SeekingAlpha
Date: April, 19 2018 16:51
Merck KGaA 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Merck KGaA in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: April, 19 2018 16:43
Procter & Gamble (PG) To Acquire Consumer Health Business Of Merck KGaA - Slideshow
The following slide deck was published by The Procter & Gamble Company in conjunction with this Read more ...
Source: SeekingAlpha
Date: April, 19 2018 13:17
Mylan aiming for Merck KGaA's consumer unit
Reuters reports that Mylan N.V. (NASDAQ: MYL ) is is advanced discussions with Merck KGaA ( OTCPK:MKGAF ) to purchase its consumer health unit for €3.5B - 4B ($4.3B - 4.9B). More news on: Mylan Inc, Merck KGaA, Healthcare stocks news, Merger & acquisition news, Consumer stocks...
Source: SeekingAlpha
Date: April, 13 2018 07:12
Merck's (MKGAF) CEO Stefan Oschmann on Q4 2017 Results - Earnings Call Transcript
Merck KGaA (MKGAF) Q4 2017 Results Earnings Conference Call March 8, 2018, 08:00 AM ET Executives Constantin Fest - Head of Investor Relations Stefan Oschmann - Chairman and Chief Executive Officer Marcus Kuhnert - Chief Financial Officer Analysts Peter Verdult - Citigroup ...
Source: SeekingAlpha
Date: March, 08 2018 22:19
Merck KGaA 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Merck KGaA in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: March, 08 2018 09:19

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-14101.931101.92101.931101.001,207
2018-08-13102.40100.65102.40100.65125
2018-08-10N/A104.75N/AN/A0
2018-08-09N/A104.75N/AN/A0
2018-08-08N/A104.75N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1625050050.0000Short
2018-08-144041,20733.4714Cover
2018-08-137512560.0000Short
2018-07-2510010298.0392Short
2018-07-1231086036.0465Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MKGAF.


About Merck KGaA (OTC: MKGAF)

Logo for Merck KGaA (OTC: MKGAF)

Merck KGaA is a global pharmaceutical, chemical and life science company with a history that began in and a future shaped by approximately , employees in countries. Merck KGaA s subsidiaries in North America operate using the umbrella brand EMD .

 

 

 

Current Management

  • KarlLudwig Kle Kley / CEO
  • Matthias Zachert / CFO
  • Constantin Fest / IR
  • IR Investor Relations / IR

Current Share Structure

  • Market Cap: $36,775,886,506 - 03/09/2018
  • Issue and Outstanding: 387,726,795 - 03/14/2016

 


Recent Filings from (OTC: MKGAF)

Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: July, 25 2017
Registration of depository shares evidenced by American Depository Receipts
Filing Type: F-6Filing Source: edgar
Filing Date: July, 18 2017

 

 


Daily Technical Chart for (OTC: MKGAF)

Daily Technical Chart for (OTC: MKGAF)


Stay tuned for daily updates and more on (OTC: MKGAF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MKGAF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MKGAF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of MKGAF and does not buy, sell, or trade any shares of MKGAF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/